Wall Street analysts are currently evaluating the bullish sentiment surrounding Zimmer Biomet stock and its potential performance.

Zimmer Biomet Holdings, Inc. has released its Q2 2026 earnings call summary.

An analysis evaluates whether Zimmer Biomet Holdings, Inc. (ZBH) is a good stock to buy now.

Zimmer Biomet has announced an increase in its share repurchase target to up to $1 billion by the end of the year.

The Chief Financial Officer (CFO) of Zimmer Biomet has announced their departure from the company to take on a new job.

Leerink analysts anticipate limited near-term upside for Zimmer Biomet Holdings, Inc., with significant catalysts expected closer to 2027.

An analysis compares Zimmer Biomet Holdings' stock performance against other medical devices stocks, evaluating its standing within the sector.

Several companies, including Gran Tierra Energy, goeasy, and Finning International, have released highlights from their second-quarter earnings calls. These reports provide insights into their financial performance and operational updates for the recent quarter.

An earnings preview has been released, outlining expectations for Zimmer Biomet's upcoming financial report.

Intuitive Surgical (ISRG) and Zimmer Biomet Holdings (ZBH) are being evaluated as leading investment opportunities within the robotic surgery sector. Both companies are highlighted for their potential in this growing market.

Zimmer Biomet announced that its Chief Financial Officer, Suketu Upadhyay, will be departing from the company.

A preview of Zimmer Biomet's upcoming quarterly earnings has been released, providing insights into the company's financial performance expectations.

Zimmer Biomet has announced a dividend of $0.24 per share.

An article investigates whether Zimmer Biomet's stock is lagging behind the S&P 500 index, evaluating its performance within the healthcare sector.

Several companies and investment funds, including Lazard Global Total Return & Income Fund, Corton Enhanced Income Fund, and Frontline, have announced their latest dividend declarations. These declarations include specific per-share amounts for their respective shareholders.

Zimmer Biomet's stock price dropped to a 13-year low after the company announced the resignation of its Chief Financial Officer.

Shimmick has appointed a new Chief Operating Officer, while Incyte has tapped Zimmer Biomet's Suketu Upadhyay as its new Chief Financial Officer. These announcements reflect recent leadership changes within the companies.

Zimmer Biomet (ZBH) has published the transcript of its fourth-quarter 2024 earnings call, providing details on the company's financial performance and outlook.

A market digest provides an overview of the stock performance and related news for Zimmer Biomet Holdings (ZBH).